WallStSmart

American International Group Inc (AIG)vsTexas Capital Bancshares Inc (TCBIO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

American International Group Inc generates 2037% more annual revenue ($26.61B vs $1.25B). TCBIO leads profitability with a 28.7% profit margin vs 11.6%. TCBIO trades at a lower P/E of 5.5x. AIG earns a higher WallStSmart Score of 60/100 (C).

AIG

Buy

60

out of 100

Grade: C

Growth: 2.0Profit: 5.0Value: 7.0Quality: 7.0
Piotroski: 5/9Altman Z: 0.88

TCBIO

Buy

54

out of 100

Grade: C-

Growth: 8.7Profit: 7.5Value: 6.7Quality: 5.5
Piotroski: 7/9Altman Z: -0.54

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AIG4 strengths · Avg: 8.8/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.229/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.868/10

Growing faster than its price suggests

P/E RatioValuation
13.7x8/10

Attractively priced relative to earnings

TCBIO6 strengths · Avg: 9.7/10
P/E RatioValuation
5.5x10/10

Attractively priced relative to earnings

Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
32.2%10/10

Strong operational efficiency at 32.2%

EPS GrowthGrowth
69.6%10/10

Earnings expanding 69.6% YoY

Profit MarginProfitability
28.7%9/10

Keeps 29 of every $100 in revenue as profit

Debt/EquityHealth
0.269/10

Conservative balance sheet, low leverage

Areas to Watch

AIG4 concerns · Avg: 2.3/10
Return on EquityProfitability
7.4%3/10

ROE of 7.4% — below average capital efficiency

Revenue GrowthGrowth
-7.2%2/10

Revenue declined 7.2%

EPS GrowthGrowth
-5.6%2/10

Earnings declined 5.6%

Altman Z-ScoreHealth
0.882/10

Distress zone — elevated risk

TCBIO1 concerns · Avg: 2.0/10
Altman Z-ScoreHealth
-0.542/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AIG

The strongest argument for AIG centers on Price/Book, Debt/Equity, PEG Ratio. PEG of 0.86 suggests the stock is reasonably priced for its growth.

Bull Case : TCBIO

The strongest argument for TCBIO centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 28.7% and operating margin at 32.2%. Revenue growth of 16.9% demonstrates continued momentum.

Bear Case : AIG

The primary concerns for AIG are Return on Equity, Revenue Growth, EPS Growth.

Bear Case : TCBIO

The primary concerns for TCBIO are Altman Z-Score.

Key Dynamics to Monitor

AIG profiles as a declining stock while TCBIO is a growth play — different risk/reward profiles.

TCBIO carries more volatility with a beta of 0.67 — expect wider price swings.

TCBIO is growing revenue faster at 16.9% — sustainability is the question.

AIG generates stronger free cash flow (636M), providing more financial flexibility.

Bottom Line

AIG scores higher overall (60/100 vs 54/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American International Group Inc

FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA

American International Group, Inc., also known as AIG, is an American multinational finance and insurance corporation with operations in more than 80 countries and jurisdictions. The company operates through three core businesses: General Insurance, Life & Retirement, and a standalone technology-enabled subsidiary.

Texas Capital Bancshares Inc

FINANCIAL SERVICES · BANKS - REGIONAL · USA

Texas Capital Bancshares Inc (TCBIO), headquartered in Dallas, Texas, is a leading regional bank offering a comprehensive suite of financial services that cater to both commercial and individual clients. The firm excels in providing customized solutions including business lending, treasury management, and personal banking, driven by a strong emphasis on client relationships and in-depth local market insights. With a robust approach to risk management and a strategic focus on sustainable growth, TCBIO is strategically positioned to thrive in a competitive environment while delivering long-term value for its shareholders.

Want to dig deeper into these stocks?